Thrombin-sensitive peptide linkers for biological signal-responsive drug release systems (Q43601628)

25 November 2017

title

Thrombin-sensitive peptide linkers for biological signal-responsive drug release systems (English)

1 reference

25 November 2017

Tanihara M

1

1 reference

25 November 2017

Suzuki Y

2

1 reference

25 November 2017

Nishimura Y

3

1 reference

25 November 2017

Suzuki K

4

1 reference

25 November 2017

Kakimaru Y

5

1 reference

25 November 2017

publication date

1 January 1998

1 reference

25 November 2017

number of pages

5

1 reference

inferred from page(s)

published in

Peptides

1 reference

25 November 2017

volume

19

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

421-425

1 reference

Release of peptides from sustained delivery systems (microcapsules and microparticles) in vivo. A histological and immunohistochemical study

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

Synthetic substrates for thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

Highly sensitive peptide-4-methylcoumaryl-7-amide substrates for blood-clotting proteases and trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

New methods of drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

1 reference

7 January 2021

Mechanism of action of thrombin on fibrinogen. Direct evidence for the involvement of phenylalanine at position P9

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

New Fluorogenic Substrates for α-Thrombin, Factor Xa, Kallikreins, and Urokinase1

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

Clinical trials with Dismutec (pegorgotein; polyethylene glycol-conjugated superoxide dismutase; PEG-SOD) in the treatment of severe closed head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

Expression of stromelysin 3 and tissue inhibitors of matrix metallo-proteinases, TIMP-1 and TIMP-2, in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

Controlled release of LHRH agonist, leuprolide acetate, from microcapsules: serum drug level profiles and pharmacological effects in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2897%2900420-8

7 January 2021

10.1016/S0196-9781(97)00420-8

Identifiers

DOI

1 reference

25 November 2017

1 reference